Immunogenicity and Safety of a 9-valent Human Papillomavirus Vaccine in HIV-positive Women
Conditions: HIV Infections; HPV Infection Intervention: Biological: Human Papillomavirus 9-valent Vaccine, Recombinant Sponsors: University Hospital Virgen de las Nieves; Instituto de Salud Carlos III Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cervical Cancer Vaccine | Gardasil | Genital Warts | Human Papillomavirus (HPV) | Research | Vaccines | Women